Clinical Trial Matching & Patient Support
Clinical trials can be life-saving, but the process of participating in them can be overwhelming mentally and physically. Our team helps patients understand the process, and navigate every step of participation.
Connect with Our TeamHow We Help Patients
Participating clinical research trials can feel overwhelming. We're here to make sense of it and easy to navigate.
Trial Matching
We connect patients with clinical trials that match their diagnosis, location, and health profile — at no cost.
Study Logistics
We help you understand visit schedules, and potential study-related logistics including time commitment.
Financial Information
Understand financial consequences of participating in medical research and what that may mean for your financial wellbeing.
Privacy & Rights
Your rights as a research participant are protected by federal law. We explain informed consent, HIPAA, and your right to withdraw.
Currently Recruiting Clinical Trials
A current selection of studies actively enrolling participants, sourced directly from the public ClinicalTrials.gov registry. Click any study to read its full details.
Training Protocol on the Natural History of Tuberculosis
Conditions: Mycobacterium Infections, Tuberculosis, Multidrug-Resistant, Latent Tuberculosis…
📍Bethesda, Maryland, United States
🏛️National Institute of Allergy and Infectious Diseases (NIAID)
NCT01212003
A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
Conditions: Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL)…
📍Auckland, Auckland, New Zealand (+2 more)
🏛️Malaghan Institute of Medical Research
NCT06486051
Quality of Recovery After Childbirth
Conditions: Quality of Life, Childbirth, Maternal Health
📍Singapore, Singapore
🏛️KK Women's and Children's Hospital
NCT04989894
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
Conditions: HIV/AIDS, Hepatitis C, Substance Use Disorders…
📍New York, New York, United States
🏛️Columbia University
NCT03135886
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
📍Mobile, Alabama, United States (+200 more)
🏛️Merck Sharp & Dohme LLC
NCT06136559
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Conditions: Triple-Negative Breast Cancer
📍Mobile, Alabama, United States (+307 more)
🏛️Merck Sharp & Dohme LLC
NCT06393374
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Conditions: Lymphoma, Leukemia
📍Los Angeles, California, United States (+2 more)
🏛️National Cancer Institute (NCI)
NCT05237986
Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
Conditions: Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Lung Cancer (Non-Small Cell)…
📍Kaohsiung, Taiwan, Taiwan
🏛️Kaohsiung Medical University Chung-Ho Memorial Hospital
NCT07751783
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Conditions: Acute Myeloid Leukemia
📍Brighton, Michigan, United States (+6 more)
🏛️National Cancer Institute (NCI)
NCT07437950
Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)
Conditions: Coloboma, Anophthalmia, Microphthalmia
📍Bethesda, Maryland, United States
🏛️National Eye Institute (NEI)
NCT01778543
Comparison of the Effects of Long-Term Rowing Training in Professional Rowers
Conditions: Rowing
📍Tunceli, Turkey (Türkiye)
🏛️Hacettepe University
NCT07752927
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Conditions: Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
📍Los Angeles, California, United States (+22 more)
🏛️Verastem, Inc.
NCT07644559
This is a small sample of active studies. Explore the full registry of recruiting trials at ClinicalTrials.gov.
Trial information is sourced from the public ClinicalTrials.gov registry, courtesy of the U.S. National Library of Medicine. Listings are submitted and maintained by individual study sponsors and investigators and are not verified or endorsed by ClinOps Consulting, the National Library of Medicine, or the National Institutes of Health. Always confirm current details on the official study record before making any decisions.
Frequently Asked Questions
Common questions patients ask before considering a clinical trial.
Important Disclaimer
The information on this page is provided for general educational purposes only and does not constitute medical, legal, or financial advice. It is not a substitute for the guidance of a qualified healthcare professional. Always consult your physician or another qualified provider with any questions about a medical condition or before making decisions about clinical trial participation.
Clinical trial listings shown here are drawn from the public ClinicalTrials.gov registry and are maintained by the individual study sponsors and investigators. ClinOps Consulting does not run, vet, or endorse these studies, cannot guarantee the accuracy, completeness, or current status of any listing, and is not affiliated with the National Library of Medicine or the National Institutes of Health. Eligibility, enrollment status, and study details may change at any time — verify all information on the official study record.
Contacting ClinOps Consulting does not guarantee placement in any clinical trial or any particular outcome, and does not create a physician–patient relationship.
Get in Touch
Tell us what you're looking for and our patient support team will be in touch. All information is kept confidential.